Abstract
Interleukin 1 (IL 1) is a cytokine which was initially defined as an immunologically nonspecific monocyte/ macrophage-derived factor that enhances the proliferative response of murine thymocytes (1). In this article we will briefly review recent information concerning the formation and properties of IL 1. In addition, we will present data suggesting that IL 1 may be an autostimulating signal for human monocytes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Oppenheim JJ, Gery I: Interleukin 1 is more than an interleukin. Immunol. Today 1982, 3: 113–119.
Arenzana-Seisdedos F, Virelizier J-L: Interferons as macrophages-activating factors II. Enhanced secretion of IL 1 by LPS-stimulated human monocytes. Eur J Immunol 1983, 13: 437–440.
Gery I, Lepe-Zuniga JL: Interleukin 1: Uniqueness of its production and spectrum of activities. In: Lymphokines. A forum for immunoregulatory cell products. Vol 9. Pick E, ed. Academic Press, New York 1984, pp. 109–125.
Mizel SB, Rosenstreich DL: Regulation of lymphocyte activating factor (LAF) production and secretion in P388D1 cells: Identification of high molecular weight precursors of LAF. J Immunol 1979, 122: 2173–2179.
Smith KA, Ruscetti FW: T cell growth factor and the culture of cloned functional T-cells. Adv Immunol 1982, 31: 139–173.
Simon PL, Willoughby JB, Willoughby WF: Inhibition of T cell activation by alpha-l-antiprotease is reversed by purified rabbit IL1. In: Oppenheim JJ and Cohen S, eds. Interleukins, Lymphokines, Cytokines. Academic Press, New York 1983, pp. 487–493.
Kimball ES, Pickeral SF, Oppenheim JJ, Rossio JL: Interleukin 1 activity in normal human urine. J Immunol 1984, 133: 256–260.
Liao Z, Grimshaw RS, Rosenstreich DL: Identification of a specific IL 1 inhibitor in the urine of febrile patients. J Exp Med 1984, 159: 126–136.
Scala G, Kuang YD, Hall RD, Muchmore AV, Oppenheim JJ: Accessory cell function of human B cells. I. Production of both IL 1-like activity and IL 1 inhibitory factor by an EBV-transformed human B-cell line. J Exp Med 1984, 159: 1637–1652.
Fontana A, Hengartner H, DeTribolet N, Weber E: Glioblastoma cells release IL l and factors inhibiting IL 2-mediated effects. J Immunol 1984, 132: 1837–1844.
Oppenheim JJ, Scala G, Kuang Y, Matsushima K, Sztein MB, Steeg PS: The role of cytokines in promoting accessory cell functions. Prog Immunol 1984, 5: 285–293.
Fontana A, Kristensen F, Dubo R, Gerasa D, Weber E: Production of prostaglandin E and an interlcukin 1-like factor by cultured astrocytes and C, glioma cells. J Immunol 1982, 129: 2413–2419.
Fisher RI, Bostick-Bruton F, Sauder DN, Scala G. Diehl V: Neoplastic cells obtained from Hodgkin’s disease are potent stimulators of human primary MLC. J Immunol 1983, 130: 2666–2670.
Wagner C, Vetto RM, Burger DR: The mechanism of antigen presentation by endothelial cells. Immunobiology 1984, 168: 453–469.
Scala G, Djeu JY, Allavena P, Kasahara T, Ortaldo JR, Herberman RB, Oppenheim JJ: Human large granular lymphocytes (LGL) are potent producers of IL1. Nature 1984, 309: 56–59.
Lipsky PE, Thompson PA, Rosenwasser LJ, Dinarello CA: The role of interleukin 1 in human B cell activation. J Immunol 1983, 130: 2708–2714.
Postlewaite AE, Lachman LB, Mainardi CL, Kang AH: Interleukin 1 stimulation of collagenase production by cultured fibroblasts. J Exp Med 1983, 157: 801–806.
Gowen M, Wood DD, Ihrie EJ, McGuire MKB, Graham R, Russell G: An IL 1 like factor stimulates bone resorbtion in vitro. Nature 1983, 306: 378–380.
Schnyder J, Evêquoz V, Trechsel U, Baggiolini M: Influence of macrophage products on enzyme and prostaglandin E2 release by chondrocytes. This volume.
Baracos V, Rodeman HP, Dinarello CA, Goldberg AL: Stimulation of muscle protein degradation and PGF, release by leukocyte pyrogen (IL1). New Eng J Med 1983, 308: 553–558.
Berilacqua MP, Pober JS, Cotran RS, Gimbrone Jr MA: Effects of mononuclear phagocytes and their secretory products on vascular endothelium. This volume.
Lovett DL, Ryan JL, Sterzel RB: Stimulation of rat mesangial cell proliferation by macrophage IL 1. J Immunol 1983, 131: 2830–2836.
Matsushima K, Bano M, Kidwell WR, Oppenheim JJ: Interleukin 1 increases collagen type IV production by mammary epithelial cells. J Immunol 1985, 134: 904–909.
Luger TA, Charon JA, Colot M, Micksche M, Oppenheim JJ: Chemotatic properties of partially purified human epidermal cell-derived thymocyte-activating factor (TAF) for polymorphonuclear and mononuclear cells. J Immunol 1983, 131: 816–820.
Dinarello CA, Marnoy SO, Rosenwasser LJ: Role of arachiondate metabolism in the immunoregulatory function of human leukocyte pyrogen/lymphocyte activating factor IL1. In: Oppenheim JJ, Cohen S eds. Interleukins, Lymphokines, Cytokines. Academic Press, New York 1983, pp. 495–507.
Kleinerman ES, Schroitt AJ, Fogler WE, Fidler IJ: Tumoricidal activity of human monocytes activated in vitro by free and liposome-encapsulated human lymphokines. J Clin Invest 1983, 72: 304–315.
Perusia B, Trinchieri G: Antibody 3G8, specific for the human neutrophil Fc receptor reacts with natural killer cells. J Immunol 1984, 132: 1410–1415.
Le J, Prensky W, Yip YK, Chang Z, Hoffman T, Stevenson HC, Balazs I, Sadlik JR, Vilcek J: Activation of human monocyte cytotoxicity by natural and recombinant immune interferon. J Immunol 1983, 131: 2821–2826.
Kleinerman ES, Zicht R, Sarin PS, Gallo RC, Fidler IJ: Constitutive production and release of a lymphokine with macrophage activating factor (MAF) activity distinct from ‘y-interferon by a human T cell leukemia virus positive cell line. Cancer Res 1984, 44: 4470–4475.
Kleinerman ES, Ceccorulli LM, Bonvini E, Zicht R, Gallin JI: Human monocytes lyse tumor cells via a mechanism that is independent of superoxide (02) and hydrogen peroxide (H202). Clinical Res. 1984, 32: 417A.
Dore-Duffy P, Perry W, Kuo HH: Interferon-mediated inhibition of prostaglandin synthesis in human mononuclear leukocytes. Cell Immunol 1983, 79: 232–239.
Weinberg JB, Haney HF: Spontaneous tumor cell killing by human blood monocytes and human peritoneal macrophages: Lack of alteration by endotoxin or quenchers of reactive oxygen species. J Natl Cancer Inst 1983, 70: 1005–1010.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Martinus Nijhoff Publishers, Dordrecht
About this chapter
Cite this chapter
Oppenheim, J.J., Onozaki, K., Matsushima, K. (1985). Autoregulatory effects of interleukin 1 on human monocytes. In: van Furth, R. (eds) Mononuclear Phagocytes. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-5020-7_29
Download citation
DOI: https://doi.org/10.1007/978-94-009-5020-7_29
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8723-0
Online ISBN: 978-94-009-5020-7
eBook Packages: Springer Book Archive